Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Soleno Therapeutics, Inc. - Common Stock
(NQ:
SLNO
)
53.01
UNCHANGED
Last Price
Updated: 4:00 PM EDT, May 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Soleno Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
Soleno Therapeutics Inc (NASDAQ:SLNO): A Decent Value Play with Strong Health and Explosive Growth Potential
↗
April 27, 2026
Via
Chartmill
Neurocrine Biosciences to Acquire Celeno Therapeutics in Rare Disease Deal
April 07, 2026
In a move that signals a significant consolidation within the rare endocrine disease market, Neurocrine Biosciences (NASDAQ: NBIX) announced on April 6, 2026, that it has entered into a definitive...
Via
MarketMinute
Soleno Therapeutics: A Masterclass in Rare Disease Redemption and the $2.9B Exit
April 07, 2026
The following feature explores the trajectory of Soleno Therapeutics as of April 7, 2026. Introduction On the morning of April 7, 2026, the biotechnology sector is processing one of the most...
Via
Finterra
Topics
Economy
Intellectual Property
Wall Street Holds Its Ground While Trump's Iran Deadline Ticks Down
↗
April 07, 2026
Via
Chartmill
Topics
Government
Soleno Therapeutics Inc (NASDAQ:SLNO) Emerges as a Potential Fair-Value Opportunity
↗
March 16, 2026
Via
Chartmill
Soleno Therapeutics (NASDAQ:SLNO) Beats Q4 2025 Estimates Amid Cautious Market Reaction to VYKAT XR Launch
↗
February 25, 2026
Via
Chartmill
Stock Market Today, April 6: Soleno Therapeutics Climbs After $2.9 Billion All-Cash Buyout Agreement
↗
April 06, 2026
Neurocrine’s rare-disease push, anchored by Soleno’s VYKAT XR, reshapes biotech dealmaking focus, today, April 6, 2026.
Via
The Motley Fool
Topics
Intellectual Property
Stocks
Why Soleno Therapeutics Stock Rocketed Higher on Monday
↗
April 06, 2026
It's being acquired by a peer.
Via
The Motley Fool
Monday's session: top gainers and losers
↗
April 06, 2026
Via
Chartmill
Neurocrine Biosciences to Acquire Soleno Therapeutics in $2.9 Billion Deal as VYKAT™ XR Sales Soar
April 06, 2026
Shares of Soleno Therapeutics (NASDAQ: SLNO) surged more than 32% in early trading on Monday, April 6, 2026, following the blockbuster announcement that Neurocrine Biosciences (NASDAQ: NBIX) has...
Via
MarketMinute
Topics
Intellectual Property
Which stocks are moving on Monday?
↗
April 06, 2026
Via
Chartmill
Monday's session: gap up and gap down stocks
↗
April 06, 2026
Via
Chartmill
Stay updated with the stocks that are on the move in today's pre-market session.
↗
April 06, 2026
Via
Chartmill
Why Applied Optoelectronics Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
↗
April 06, 2026
Applied Optoelectronics Inc (NASDAQ: AAOI) rose in pre-market trading after securing an 800G transceiver order worth $71 million, bringing total orders from a major customer to $124 million. Other...
Via
Benzinga
READYSTATE Dumps 361,000 Workiva Shares Worth $32 Million
↗
March 17, 2026
This technology firm provides cloud-based compliance and reporting solutions for organizations with complex regulatory needs worldwide.
Via
The Motley Fool
Topics
Regulatory Compliance
Aardvark Therapeutics Becomes Next Pharma Player To Quit Prader-Willi Syndrome Drug Development Efforts
↗
February 27, 2026
The company said that the decision was based on certain cardiac observations made during routine safety monitoring in a healthy volunteer study.
Via
Stocktwits
Soleno (SLNO) Q4 2025 Earnings Call Transcript
↗
February 25, 2026
Soleno (SLNO) Q4 2025 Earnings Call Transcript
Via
The Motley Fool
Topics
Earnings
Rhythm Pharmaceuticals Faces Gravity: FDA Delays and Valuation Pressures Cool 2025’s Biotech Darling
December 30, 2025
As the final trading days of 2025 wind down, Rhythm Pharmaceuticals (Nasdaq: RYTM) finds itself at a critical crossroads. After a meteoric rise that saw the stock gain over 100% through the first three...
Via
MarketMinute
Topics
ETFs
Economy
World Trade
Soleno Turns First Profit on $66 Million in Revenue — Is This Why One Investor Just Made an $87 Million Bet?
↗
December 03, 2025
Soleno just turned profitable for the first time—right as a major fund made its move.
Via
The Motley Fool
Topics
Regulatory Compliance
Soleno Therapeutics Unveils $100 Million Buyback Citing 'Underappreciated' Future
↗
November 11, 2025
Soleno Therapeutics (SLNO) approved $100M share repurchase program & entered ASR agreement with Jefferies LLC to buy back its stock.
Via
Benzinga
PubMatic Posts Upbeat Q3 Results, Joins Energy Vault, RealReal And Other Big Stocks Moving Higher On Tuesday
↗
November 11, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
November 11, 2025
Via
Benzinga
These stocks are moving in today's session
↗
November 05, 2025
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
November 05, 2025
Via
Benzinga
Wednesday's session: gap up and gap down stocks
↗
November 05, 2025
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the gap up and gap down stocks in today's session.
Via
Chartmill
Super Micro Computer Posts Downbeat Q1 Results, Joins Pinterest, Axon Enterprise And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
↗
November 05, 2025
Via
Benzinga
These stocks that are showing activity before the opening bell on Wednesday.
↗
November 05, 2025
The US market is yet to commence its session on Wednesday, but let's get a preview of the pre-market session and explore the top gainers and losers driving the early market movements.
Via
Chartmill
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
November 05, 2025
Via
Benzinga
Why Teradata Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
↗
November 05, 2025
Via
Benzinga
What's going on in today's after hours session
↗
November 04, 2025
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.
Via
Chartmill
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit